Analyst Expect Big Moves From Arcutis Biotherapeutics Inc (NASDAQ: ARQT)
Currently, there are 96.79M common shares owned by the public and among those 78.91M shares have been available to trade. Insiders at the company have transacted a total of 49 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 22 of these insider trades were purchases, […]
Institutional Exposure To Arcutis Biotherapeutics Inc (ARQT)
Arcutis Biotherapeutics Inc (ARQT) concluded trading on Wednesday at a closing price of $7.58, with 4.05 million shares of worth about $30.68 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -10.51% during that period and on Wednesday the price saw a gain of […]
Look For Institutional Buying In Arcutis Biotherapeutics Inc (NASDAQ: ARQT)
Arcutis Biotherapeutics Inc (ARQT) concluded trading on Wednesday at a closing price of $5.71, with 3.26 million shares of worth about $18.63 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -41.91% during that period and on Wednesday February 7 the price saw a […]
Reassessing The Changing Outlook For Arcutis Biotherapeutics Inc (ARQT)
Suvretta Capital Management LLC recently announced the acquisition of new stake in Arcutis Biotherapeutics Inc (NASDAQ:ARQT). The institutional investor has increased its shareholding in the Healthcare company by 744.96% to 9.59 million shares with purchase of 8.46 million shares. This fresh investment now brings its stake to 10.16% valued currently at $30.98 million. In addition, […]
Look At Analyst Expectations For A Better Read On Arcutis Biotherapeutics Inc (NASDAQ: ARQT)
Suvretta Capital Management LLC recently announced the acquisition of new stake in Arcutis Biotherapeutics Inc (NASDAQ:ARQT). The institutional investor has increased its shareholding in the Healthcare company by 744.96% to 9.59 million shares with purchase of 8.46 million shares. This fresh investment now brings its stake to 10.16% valued currently at $30.98 million. In addition, […]
Arcutis Biotherapeutics Inc (NASDAQ: ARQT) – Suitable For Long Term Buy?
Suvretta Capital Management LLC recently announced the acquisition of new stake in Arcutis Biotherapeutics Inc (NASDAQ:ARQT). The institutional investor has increased its shareholding in the Healthcare company by 744.96% to 9.59 million shares with purchase of 8.46 million shares. This fresh investment now brings its stake to 10.16% valued currently at $17.65 million. In addition, […]
Arcutis Biotherapeutics Inc (ARQT) Volatility Spurs A Quest For Clarity
Suvretta Capital Management LLC recently announced the acquisition of new stake in Arcutis Biotherapeutics Inc (NASDAQ:ARQT). The institutional investor has increased its shareholding in the Healthcare company by 744.96% to 9.59 million shares with purchase of 8.46 million shares. This fresh investment now brings its stake to 10.16% valued currently at $17.65 million. In addition, […]
